RENACER - Brain Metastasis Network

🧠Disrupting the medical pipeline for a healthier future in cancer patients. RENACER brings together a consortium of 15 national reference hospitals to challenge Brain Metastasis prevention and prognosis with a unique work strategy. Discover RENACER 👉 renacerbrainmet.org

Dr @valientelab & Dr @BenedictoC_F reflect on the brain, cancer, & the need of collaboration. From brain metastasis to science communication, they call for research with real impact. #WorldBrainDay​ ​ 🔗 Full interview: elperiodico.com/ideas/Fundacio…

🧠 Brain metastases affect up to 30% of cancer patients. Yet key aspects remain poorly understood.​ MoLab's new review in Mathematical Biosciences explores how mathematical models can predict tumour growth & treatment response. ​ 🔗 sciencedirect.com/science/articl…

The 5th RENACER General Assembly will connect professionals, researchers & all those interested in brain metastasis to learn about the new advances that are being developed in this field.​ 📅 Friday, Oct 24th​ 📍 Ramón Areces Foundation, Madrid​ 🕥 10:30 - 15:00 h

At #RENACER, we support research that brings us closer to personalised treatments.​ This study led by Zhu et al. uses organotypic cultures to identify vulnerabilities in brain metastases. A major step forward!​ ​ 🔗 pubmed.ncbi.nlm.nih.gov/35174975/

The 2025 @EACRnews Congress is the key meeting for cancer researchers tackling brain metastases. Topics like tumour evolution & immune evasion are vital for advancing personalised medicine. RENACER is proud to connect teams driving this progress. 🧬 🔗 2025.eacr.org

El 8 de junio se conmemora el #DíaInternacionaldelosTumoresCerebrales. Estos tumores plantean enormes desafíos para la investigación. En nuestro blog te contamos por qué son tan difíciles de abordar y qué avances se están logrando. blog.contraelcancer.es/investigacion-…

Los grandes retos de la investigación en tumores cerebrales blog.contraelcancer.es/investigacion-…

We are excited to share this article from @elmundoes, which focuses on our work to improve brain metastasis treatment. With the participation of patients, healthcare professionals, and project leaders, the article highlights the challenges of treating brain metastases and the…

This year’s #NMMSymposium spotlighted key advances in #neurooncology: from single-cell tech to AI imaging and immunotherapy. Topics that resonate deeply with our work at #RENACER.​ ​ 🔗 nmn-society.org/program/

🧠 At #ASCO2025, Dr Juan Manuel Sepúlveda (Hospital 12 de Octubre & #RENACER) presented early results from the CAN-201 NDG trial testing azeliragon + standard care in glioblastoma. ✅ Safe so far, with promising signs of delayed progression. 📄 ascopubs.org/doi/pdf/10.120……

At #RENACER, we join the#EuropeanWeekAgainstCancer to highlight the need for prevention, early detection & equal access to treatment. We work to better understand brain metastases & bring precision medicine to patients across Spain. 🧠🎗️ #CancerResearch

Today on #ClinicalTrialsDay, we highlight their key role in advancing medicine. At #RENACER, we’re building the knowledge needed for future trials in brain metastases, a cancer complication still lacking effective treatments. 🧠

Brain metastases are major challengein oncology. At RENACER, we are changing this with a unique workflow to collect, analyse, and classify them. Our approachdrives better treatmentsand outcomes. Discovermore in ournew infographic! 🔗 renacerbrainmet.org/renacer/

It was a great to reconnect with the #RENACER network during our General Assembly and share: 🧠 New hospitals & collaborators ⚙️ Methodological updates 📰 Exciting scientific results ⚕️ Translational projects & clinical trials 💪 Future goals Thanks to everyone involved! 💙

Muchas gracias @diariomedico Enhorabuena a Ascension y Jose Ramon, unos cracks. Gracias a todo el personal sanitario que apoya @RenacerBrainMet diariamente y al @valientelab por su motivacion contagiosa. Al @CNIOStopCancer por ser un entorno excelente para investigar en cancer.

We welcome @hospitaldelmar and @santiagosergas to our growing network! 🏥🧠 With21 hospitals across Spain, RENACER brings together clinical experts to drive research into brain metastases and improve patient care. 🔗 renacerbrainmet.org/es/miembros-y-…

🧬 On #InternationalDNADay, we highlight a key challenge in oncology: the genetic diversity of tumours. At RENACER, we are working to turn these discoveries into personalised therapies.​ Read more 👉 pubmed.ncbi.nlm.nih.gov/35120664/

Research is the foundation of a healthier future. 🔬 That’s why we are working to advance the next generation of personalised medicine for brain metastases. Learn more about our research with @valientelab! 👇 🔗 youtube.com/embed/1IGtva2E… #WorldHealthDay

📊✨ En el #DíaInternacionalDeLasMatemáticas destacamos cómo los modelos matemáticos pueden predecir la recurrencia de metástasis cerebrales tras radioterapia. Un estudio de @molab_uclm abre la puerta a tratamientos más personalizados. ​ 📖 Lee más aquí: buff.ly/4beiWUZ

En la #SemanaDelCerebro reforzamos nuestro compromiso para afrontar las metástasis cerebrales de manera multidisciplinar, avanzando hacia tratamientos más efectivos y menos agresivos para mejorar la vida de los pacientes.🧠💙​ #MetástasisCerebrales #InvestigaciónOncológica